Apellis Pharmaceuticals, Inc. Soared

Tue 07 Jan 20 at 05:30 PM
Apellis Pharmaceuticals, Inc. Soared

Apellis Pharmaceuticals, Inc. (APLS:NASDAQ) rocketted at $38.73, a gain of 28.3%. The stock appeared on our News Catalysts scanner on Tue 07 Jan 20 at 05:02 PM in the 'PUBLIC OFFERING' category. From Fri 13 Dec 19, the stock recorded 64.29% Up Days and 66.67% Green Days

The share price of the company has been moving sideways in recent weeks.

About Apellis Pharmaceuticals, Inc. (APLS:NASDAQ)

Apellis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of novel therapeutic compounds for autoimmune and inflammatory diseases.

Share